FDA restrictions don’t go far enough to address the E-cigarette epidemic
Earlier today, the Food and Drug Administration (FDA) released a draft guidance that seeks to limit youth access to some […]
Earlier today, the Food and Drug Administration (FDA) released a draft guidance that seeks to limit youth access to some […] DURHAM, N.C.–(BUSINESS WIRE)–Mar. 12, 2019– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the […] MONDAY, Feb. 25, 2019 — Despite claims to the contrary, thermography should not be used in place of mammography for […] TUESDAY, Feb. 19, 2019 — Drug makers and federal regulators dropped the ball in tracking the use of a potentially […] Hill’s Pet Nutrition announced the voluntary recall this week. (iStock) The U.S. Food and Drug Administration (FDA) has announced the […] DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved […] The hemp industry still has work ahead to win legal status for hemp-derived cannabidiol, or CBD oil, as an ingredient […] NEW YORK, December 21, 2018 (GLOBE NEWSWIRE) – Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and […] Last Updated Nov 13, 2018 3:45 PM EST Just days after reports that the Food and Drug Administration is planning […] RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food […]FDA
FDA restrictions don’t go far enough to address the E-cigarette epidemic
FDA Approves Rocklatan
FDA: Thermography No Substitute for Mammograms
FDA Fell Short in Preventing Fentanyl Abuse Crisis, Report Claims
Select canned dog food recalled over vitamin D levels, FDA says
Horizon Pharma plc Announces FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns
FDA casts shadow on hemp win, calling CBD products illegal
FDA Approves Elzonris (tagraxofusp-erzs), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy
Juul to halt sales of flavored e-cigarettes in retail stores
FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma
Copyright © 2024